Trinity Biotech Files Routine 6-K Report
Ticker: TRIB · Form: 6-K · Filed: May 28, 2024 · CIK: 888721
| Field | Detail |
|---|---|
| Company | Trinity Biotech PLC (TRIB) |
| Form Type | 6-K |
| Filed Date | May 28, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $15 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
TL;DR
Trinity Biotech just filed a standard 6-K, no major news here.
AI Summary
Trinity Biotech plc filed a Form 6-K on May 28, 2024, reporting for the month of May 2024. The company, based in Ireland, is a foreign private issuer and is filing its report under the Securities Exchange Act of 1934. This filing does not appear to contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates Trinity Biotech plc is fulfilling its regular reporting obligations as a foreign private issuer with the SEC. It does not contain new material information but confirms ongoing compliance.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material information that would typically impact risk.
Key Players & Entities
- TRINITY BIOTECH PLC (company) — Registrant
- 0000888721 (company) — Central Index Key
- 2835 (company) — Standard Industrial Classification Code
- 000-22320 (company) — SEC File Number
- 24986309 (company) — Film Number
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of May 2024.
What is the company's principal executive office address?
The company's principal executive office is located at IDA Business Park, Bray, Co. Wicklow, Ireland.
Does Trinity Biotech file annual reports under Form 20-F or 40-F?
Yes, Trinity Biotech indicates it files annual reports under cover of Form 20-F.
What is Trinity Biotech's Standard Industrial Classification code?
Trinity Biotech's Standard Industrial Classification code is 2835, for In Vitro & In Vivo Diagnostic Substances.
When was this Form 6-K filed?
This Form 6-K was filed on May 28, 2024.
Filing Stats: 611 words · 2 min read · ~2 pages · Grade level 14.4 · Accepted 2024-05-28 07:55:23
Key Financial Figures
- $15 million — es ("MVPHS") remained below the minimum $15 million for continued inclusion on The Nasdaq G
Filing Documents
- zk2431512.htm (6-K) — 16KB
- exhibit_99-1.htm (EX-99.1) — 276KB
- image1.jpg (GRAPHIC) — 90KB
- 0001178913-24-001848.txt ( ) — 418KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TRINITY BIOTECH PLC Trinity Biotech plc (Registrant) By: /s/Des Fitzgerald Des Fitzgerald Interim Chief Financial Officer Date: May 28, 2024